8-K Announcements
6Material company update
Apr 13, 2026·SEC
Material company update
Apr 10, 2026·SEC
Material company update
Mar 24, 2026·SEC
ASP Isotopes Inc. Common Stock(ASPI)Earnings, Financials & Key Ratios
ASPI•NASDAQ
$5.54
$517M mkt cap·Price updated May 6, 2026
AboutASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.Show more
- Revenue$4M+857.0%
- EBITDA-$26M-61.7%
- Net Income-$32M-98.5%
- EPS (Diluted)-0.63-28.6%
- Gross Margin38.6%+20.3%
- EBITDA Margin-624.54%+83.1%
- Operating Margin-635.91%+82.8%
- Net Margin-780.21%+79.3%
- ROE-92.39%+18.7%
- ROIC-98.61%+12.6%
- Debt/Equity0.74+548.3%
- Interest Coverage-101.80+24.8%
ASPI Key Insights
ASP Isotopes Inc. Common Stock (ASPI) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 18 (bottom 18%)
- ✗Shares diluted 68.4% in last year
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
ASPI Price & Volume
ASP Isotopes Inc. Common Stock (ASPI) stock price & volume — 10-year historical chart
Loading chart...
ASPI Growth Metrics
ASP Isotopes Inc. Common Stock (ASPI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM147.78%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-286.48%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-140.21%
Return on Capital
10 Years-58.84%
5 Years-58.84%
3 Years-65.74%
Last Year-47.14%
ASPI Recent Earnings
ASP Isotopes Inc. Common Stock (ASPI) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 0/12 qtrs (0%)●Beat Revenue 2/12 qtrs (33%)
Q2 2026Latest
Apr 10, 2026EPS
$0.84
Est $0.14
-514.6%
Revenue
$17M
Est $2M
+719.3%
Q4 2025
Nov 19, 2025EPS
$0.15
Est $0.15
+0.0%
Revenue
$5M
Est $2M
+140.8%
Q3 2025
Aug 14, 2025EPS
$1.03
Est $1.03
+0.0%
Revenue
$1M
Est $2M
-25.1%
Q2 2025
May 20, 2025EPS
$0.12
Est $0.12
+0.0%
Revenue
$1M
Est $7M
-83.8%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 10, 2026 | $0.84vs $0.14-514.6% | $17Mvs $2M+719.3% |
| Q4 2025 | Nov 19, 2025 | $0.15vs $0.15+0.0% | $5Mvs $2M+140.8% |
| Q3 2025 | Aug 14, 2025 | $1.03vs $1.03+0.0% | $1Mvs $2M-25.1% |
| Q2 2025 | May 20, 2025 | $0.12vs $0.12+0.0% | $1Mvs $7M-83.8% |
Based on last 12 quarters of dataView full earnings history →
ASPI Peer Comparison
ASP Isotopes Inc. Common Stock (ASPI) competitors in Nuclear materials and mineral development — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 NTIC | 75.85M | 8.00 | 4444.44 | -0.97% | -0.35% | -0.4% | 0.17 | |
 LEU | 4.38B | 231.32 | 59.31 | 1.52% | 13.4% | 10.71% | 1.59 | |
 UEC | 7.72B | 15.77 | -78.85 | 297.38% | -403.64% | -7.09% | 0.00 | |
 NNE | 1.47B | 29.07 | -27.42 | -7.25% | 0.02 | |||
 UUUU | 5.83B | 23.50 | -63.51 | -15.61% | -82.7% | -10.16% | 0.99 | |
 DNN | 3.47B | 3.87 | -21.03 | 22.15% | -44.18% | -47.51% | 1.67 | |
 CCJ | 53.89B | 123.76 | 124.56 | 10.95% | 16.93% | 8.76% | 0.15 | |
 SMR | 2.22B | 13.54 | -6.24 | -100% | -5.95% | -87.38% |
Compare ASPI vs Peers
ASP Isotopes Inc. Common Stock (ASPI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ASPI Income Statement
ASP Isotopes Inc. Common Stock (ASPI) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 433.03K | 4.14M | 8.38M |
| Revenue Growth % | - | - | - | 857.04% | 147.78% |
| Cost of Goods Sold | 19.38K | 72.57K | 294.06K | 2.54M | 6.46M |
| COGS % of Revenue | - | - | 67.91% | 61.4% | - |
| Gross Profit | -19.38K▲ 0% | -72.57K▼ 274.5% | 138.97K▲ 291.5% | 1.6M▲ 1051.0% | 1.93M▲ 0% |
| Gross Margin % | - | - | 32.09% | 38.6% | 23% |
| Gross Profit Growth % | - | -274.54% | 291.5% | 1051.05% | - |
| Operating Expenses | 2.59M | 5.1M | 16.18M | 27.95M | 44.46M |
| OpEx % of Revenue | - | - | 3736.72% | 674.51% | - |
| Selling, General & Admin | 2.55M | 3.83M | 15.42M | 24.81M | 37.54M |
| SG&A % of Revenue | - | - | 3560.15% | 598.77% | - |
| Research & Development | 41.61K | 1.27M | 764.58K | 3.14M | 6.92M |
| R&D % of Revenue | - | - | 176.57% | 75.74% | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.61M▲ 0% | -5.1M▼ 95.5% | -16.04M▼ 214.6% | -26.35M▼ 64.3% | -42.54M▲ 0% |
| Operating Margin % | - | - | -3704.63% | -635.91% | -507.38% |
| Operating Income Growth % | - | -95.51% | -214.61% | -64.28% | - |
| EBITDA | -2.59M | -5.03M | -16M | -25.88M | -41.51M |
| EBITDA Margin % | - | - | -3695.98% | -624.54% | -495.2% |
| EBITDA Growth % | - | -94.17% | -218.41% | -61.72% | -86.44% |
| D&A (Non-Cash Add-back) | 19.38K | 72.57K | 37.43K | 471.42K | 1.02M |
| EBIT | -2.61M | -4.95M | -16.18M | -32.05M | -107.37M |
| Net Interest Income | 115 | 3.38K | -109.47K | 979.82K | 3.46M |
| Interest Income | 115 | 3.38K | 9.07K | 1.24M | 3.86M |
| Interest Expense | 0 | 0 | 118.55K | 258.87K | 400.05K |
| Other Income/Expense | 113 | 153.91K | -258.26K | -5.96M | -62.95M |
| Pretax Income | -2.61M▲ 0% | -4.95M▼ 89.6% | -16.3M▼ 229.6% | -32.31M▼ 98.2% | -105.48M▲ 0% |
| Pretax Margin % | - | - | -3764.27% | -779.67% | -1258.22% |
| Income Tax | 0 | 0 | -6.13K | 111.45K | 104.56K |
| Effective Tax Rate % | 0% | 0% | 0.04% | -0.34% | -0.1% |
| Net Income | -2.61M▲ 0% | -4.79M▼ 83.7% | -16.29M▼ 239.9% | -32.33M▼ 98.5% | -105.56M▲ 0% |
| Net Margin % | - | - | -3761.03% | -780.21% | -1259.21% |
| Net Income Growth % | - | -83.72% | -239.92% | -98.53% | -286.48% |
| Net Income (Continuing) | -2.61M | -4.95M | -16.29M | -32.42M | -105.73M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 2.53M | 3.27M | 22.54M |
| EPS (Diluted) | -0.08▲ 0% | -0.13▼ 71.3% | -0.49▼ 276.9% | -0.63▼ 28.6% | -1.19▲ 0% |
| EPS Growth % | - | -71.28% | -276.92% | -28.57% | -140.21% |
| EPS (Basic) | -0.08 | -0.13 | -0.49 | -0.63 | - |
| Diluted Shares Outstanding | 34.36M | 35.91M | 33.07M | 55.67M | 88.55M |
| Basic Shares Outstanding | 34.36M | 35.91M | 33.07M | 55.67M | 88.55M |
| Dividend Payout Ratio | - | - | - | - | - |
ASPI Balance Sheet
ASP Isotopes Inc. Common Stock (ASPI) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|
| Total Current Assets | 3.22M | 3.3M | 10.51M | 65.74M | 173.87M |
| Cash & Short-Term Investments | 2.95M | 2.39M | 7.91M | 61.89M | 113.94M |
| Cash Only | 2.95M | 2.39M | 7.91M | 61.89M | 113.94M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 938.05K | 734.48K | 50.13M |
| Days Sales Outstanding | - | - | 790.69 | 64.69 | 898.97 |
| Inventory | 0 | 0 | 0 | 65.66K | 1.37M |
| Days Inventory Outstanding | - | - | - | 9.42 | 39.94 |
| Other Current Assets | 0 | 913K | 1.66M | 3.05M | 2.08M |
| Total Non-Current Assets | 3.92M | 9.19M | 19.68M | 28.6M | 51.85M |
| Property, Plant & Equipment | 3.92M | 9.05M | 11.97M | 23.48M | 31.9M |
| Fixed Asset Turnover | - | - | 0.04x | 0.18x | 0.30x |
| Goodwill | 0 | 0 | 3.27M | 3.17M | 6.85M |
| Intangible Assets | 0 | 0 | 0 | 0 | 1.19M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 8.14M |
| Other Non-Current Assets | 0 | 139.64K | 4.44M | -3.81M | 4.43M |
| Total Assets | 7.14M▲ 0% | 12.5M▲ 75.0% | 30.19M▲ 141.6% | 94.35M▲ 212.5% | 225.89M▲ 0% |
| Asset Turnover | - | - | 0.01x | 0.04x | 0.06x |
| Asset Growth % | - | 74.95% | 141.57% | 212.54% | 629.48% |
| Total Current Liabilities | 303.35K | 1.94M | 5.67M | 7.06M | 28.32M |
| Accounts Payable | 59.68K | 1.35M | 1.11M | 1.02M | 3.42M |
| Days Payables Outstanding | 1.12K | 6.81K | 1.38K | 146.51 | 128.56 |
| Short-Term Debt | 84.97K | 33.85K | 470.4K | 939.11K | 12.4M |
| Deferred Revenue (Current) | 0 | 0 | 882K | 882K | 3.53M |
| Other Current Liabilities | 158.7K | 140.46K | 1.97M | 1.26M | 3.89M |
| Current Ratio | 10.62x | 1.71x | 1.85x | 9.31x | 9.31x |
| Quick Ratio | 10.62x | 1.71x | 1.85x | 9.31x | 9.31x |
| Cash Conversion Cycle | - | - | - | -72.4 | 810.36 |
| Total Non-Current Liabilities | 841.62K | 742.44K | 5.68M | 41.87M | 100.96M |
| Long-Term Debt | 0 | 0 | 0 | 34.87M | 99.51M |
| Capital Lease Obligations | 841.62K | 742.44K | 1.27M | 1.25M | 4.63M |
| Deferred Tax Liabilities | 0 | 0 | 110.58K | 0 | 307.81K |
| Other Non-Current Liabilities | 0 | 0 | 4.3M | 5.74M | 5.78M |
| Total Liabilities | 1.14M | 2.68M | 11.36M | 43.18M | 129.29M |
| Total Debt | 926.6K | 822.2K | 2.14M | 37.75M | 113.66M |
| Net Debt | -2.03M | -1.57M | -5.77M | -24.14M | -285.59K |
| Debt / Equity | 0.15x | 0.08x | 0.11x | 0.74x | 0.74x |
| Debt / EBITDA | - | - | - | - | -2.74x |
| Net Debt / EBITDA | - | - | - | - | 0.01x |
| Interest Coverage | - | - | -135.32x | -101.80x | -268.41x |
| Total Equity | 6M▲ 0% | 9.82M▲ 63.7% | 18.83M▲ 91.8% | 51.17M▲ 171.7% | 96.6M▲ 0% |
| Equity Growth % | - | 63.69% | 91.81% | 171.72% | 649.81% |
| Book Value per Share | 0.17 | 0.27 | 0.57 | 0.92 | 1.09 |
| Total Shareholders' Equity | 6M | 9.82M | 16.3M | 47.9M | 74.07M |
| Common Stock | 206.53K | 359.07K | 489.23K | 720.68K | 933.77K |
| Retained Earnings | -2.61M | -7.55M | -23.84M | -56.17M | -152.56M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 18.72K | 255.03K | -920.98K | -2.16M | 949.86K |
| Minority Interest | 0 | 0 | 2.53M | 3.27M | 22.54M |
ASPI Cash Flow Statement
ASP Isotopes Inc. Common Stock (ASPI) cash flow — operating, investing & free cash flow history
| Line item | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|
| Cash from Operations | -577.69K | -2.94M | -5.41M | -16.7M | -16.7M |
| Operating CF Margin % | - | - | -1249.9% | -402.86% | - |
| Operating CF Growth % | - | -408.9% | -84.1% | -208.47% | -226.65% |
| Net Income | -2.61M | -4.95M | -16.29M | -32.42M | -105.56M |
| Depreciation & Amortization | 19.38K | 72.57K | 37.43K | 471.42B | 1.02M |
| Stock-Based Compensation | 0 | 2M | 8.74M | 8.56M | 13.06M |
| Deferred Taxes | 0 | -72.57K | 16.66K | -143.28K | -78.95K |
| Other Non-Cash Items | 2.23M | -27.96K | 924.12K | -471.41B | 67.45M |
| Working Capital Changes | -238.21K | 33.89K | 1.16M | -2.62M | 587.01K |
| Change in Receivables | 0 | 0 | 237.95K | -505.95K | 936.51K |
| Change in Inventory | 0 | 0 | 0 | -67.64K | -685K |
| Change in Payables | 59.68K | 570.6K | -224.6K | -877.47K | -553.66K |
| Cash from Investing | -2.99M | -4.47M | -2.45M | -11.37M | -38.63M |
| Capital Expenditures | -2.99M | -4.47M | -2.33M | -11.37M | -10.28M |
| CapEx % of Revenue | - | - | 538.38% | 274.42% | - |
| Acquisitions | 0 | 0 | -121.85K | 0 | 6.64M |
| Investments | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | -30M |
| Cash from Financing | 6.5M | 6.64M | 13.39M | 82.53M | 125.15M |
| Debt Issued (Net) | 46.9K | -13.05K | -180.53K | 25.72M | -419.86K |
| Equity Issued (Net) | 1000K | 1000K | 1000K | 1000K | 3M |
| Dividends Paid | 0 | 0 | 0 | -2.78T | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -1.47M | -563.47K | 2.78T | -1.01M |
| Net Change in Cash | 2.93M▲ 0% | -564.58K▼ 119.2% | 5.52M▲ 1077.5% | 53.98M▲ 878.1% | 62.37M▲ 0% |
| Free Cash Flow | -3.57M▲ 0% | -7.41M▼ 107.9% | -7.74M▼ 4.5% | -28.07M▼ 262.5% | -33.96M▲ 0% |
| FCF Margin % | - | - | -1788.28% | -677.27% | -405.14% |
| FCF Growth % | - | -107.89% | -4.46% | -262.46% | -38.71% |
| FCF per Share | -0.10 | -0.21 | -0.23 | -0.50 | -0.50 |
| FCF Conversion (FCF/Net Income) | 0.22x | 0.61x | 0.33x | 0.52x | 0.32x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 |
ASPI Key Ratios
ASP Isotopes Inc. Common Stock (ASPI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|
| Return on Equity (ROE) | -60.59% | -113.7% | -92.39% | -190.37% |
| Return on Invested Capital (ROIC) | -62.59% | -112.89% | -98.61% | -98.61% |
| Gross Margin | - | 32.09% | 38.6% | 23% |
| Net Margin | - | -3761.03% | -780.21% | -1259.21% |
| Debt / Equity | 0.08x | 0.11x | 0.74x | 0.74x |
| Interest Coverage | - | -135.32x | -101.80x | -268.41x |
| FCF Conversion | 0.61x | 0.33x | 0.52x | 0.32x |
| Revenue Growth | - | - | 857.04% | 147.78% |
ASPI SEC Filings & Documents
ASP Isotopes Inc. Common Stock (ASPI) SEC filings — annual & quarterly reports (10-K, 10-Q)
ASPI Frequently Asked Questions
ASP Isotopes Inc. Common Stock (ASPI) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
ASP Isotopes Inc. Common Stock (ASPI) reported $8.4M in revenue for fiscal year 2024.
ASP Isotopes Inc. Common Stock (ASPI) grew revenue by 857.0% over the past year. This is strong growth.
ASP Isotopes Inc. Common Stock (ASPI) reported a net loss of $105.6M for fiscal year 2024.
Dividend & Returns
Yes, ASP Isotopes Inc. Common Stock (ASPI) pays a dividend with a yield of 100.00%. This makes it attractive for income-focused investors.
ASP Isotopes Inc. Common Stock (ASPI) has a return on equity (ROE) of -92.4%. Negative ROE indicates the company is unprofitable.
ASP Isotopes Inc. Common Stock (ASPI) had negative free cash flow of $34.0M in fiscal year 2024, likely due to heavy capital investments.
Explore More ASPI
ASP Isotopes Inc. Common Stock (ASPI) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates